PMID- 27487299 OWN - NLM STAT- MEDLINE DCOM- 20170509 LR - 20220318 IS - 1423-0135 (Electronic) IS - 1018-1172 (Linking) VI - 53 IP - 1-2 DP - 2016 TI - C-Reactive Protein and Inflammatory Cytokines during Percutaneous Coronary Intervention. PG - 39-48 AB - BACKGROUND: C-reactive protein (CRP) is significantly associated with cardiovascular diseases; however, whether CRP plays a causal role in coronary artery disease has yet to be determined. In addition, the relationship between CRP, atherosclerosis, and inflammation remains controversial. METHODS AND RESULTS: Serum interleukin (IL)-6, IL-1beta, and CRP levels were determined in 160 patients at time points around percutaneous coronary intervention (PCI) with drug-eluting stent implantation. The levels were found to be at peak at 24 h post-PCI and gradually declined to the level before PCI at day 30 post-PCI. These inflammation markers around PCI have no statistical difference in the different postdilation pressures (/=18 atm) and stent number (1 and >/=2 stents) groups. Treatment of cultured human vascular smooth muscle cells (VSMCs) with a combination of IL-6 and IL-1beta at concentrations associated with PCI did not result in any significant change in the CRP mRNA levels. The IL-6-augmented CRP expression in human internal mammary arteries (IMAs) stretched with a mechanical strength of 3 g was blocked by the nuclear factor-kappaB (NF-kappaB) peptide inhibitor SN50 and not by the inactive SN50 analog SN50M. IL-6 treatment increased NF-kappaB activity in human IMAs stretched with 3 g, and this effect was further blocked by stretch-activated channel (SAC) inhibitors (streptomycin or GdCl3) and SN50. CONCLUSIONS: The current study provides evidence that increased serum IL-6, IL-1beta, and CRP levels around PCI are not different between different postdilation pressure and stent number groups. The combination of IL-6 and IL-1beta at concentrations associated with PCI cannot induce CRP expression in human VSMCs, but they can augment mechanical strain-induced CRP synthesis via the SAC-NF-kappaB pathway in human IMAs. CI - (c) 2016 S. Karger AG, Basel. FAU - Wu, Mingxin AU - Wu M AD - Division of Cardiology, Xiangtan Central Hospital, Xiangtan, PR China. FAU - Gu, Xinyuan AU - Gu X FAU - Li, Xiujuan AU - Li X FAU - Li, Yanhui AU - Li Y FAU - Zhou, Huaineng AU - Zhou H FAU - Lu, Guihua AU - Lu G FAU - Wu, ZhongKai AU - Wu Z FAU - Huang, He AU - Huang H FAU - Tang, Lilong AU - Tang L FAU - Zeng, Jianping AU - Zeng J LA - eng PT - Journal Article DEP - 20160804 PL - Switzerland TA - J Vasc Res JT - Journal of vascular research JID - 9206092 RN - 0 (IL1B protein, human) RN - 0 (IL6 protein, human) RN - 0 (Inflammation Mediators) RN - 0 (Interleukin-1beta) RN - 0 (Interleukin-6) RN - 0 (Ion Channels) RN - 0 (NF-kappa B) RN - 9007-41-4 (C-Reactive Protein) SB - IM MH - Aged MH - Angioplasty, Balloon, Coronary/instrumentation MH - C-Reactive Protein/genetics/*metabolism MH - Cells, Cultured MH - Coronary Artery Disease/blood/diagnostic imaging/genetics/*therapy MH - Drug-Eluting Stents MH - Female MH - Gene Expression Regulation MH - Humans MH - Inflammation Mediators/*blood MH - Interleukin-1beta/*blood MH - Interleukin-6/*blood MH - Ion Channel Gating MH - Ion Channels/metabolism MH - Male MH - Mammary Arteries/metabolism MH - Mechanotransduction, Cellular MH - Middle Aged MH - Muscle, Smooth, Vascular/metabolism MH - Myocytes, Smooth Muscle/metabolism MH - NF-kappa B/metabolism MH - Pressure MH - Stress, Mechanical MH - Time Factors EDAT- 2016/10/19 06:00 MHDA- 2017/05/10 06:00 CRDT- 2016/08/04 06:00 PHST- 2015/12/16 00:00 [received] PHST- 2016/06/10 00:00 [accepted] PHST- 2016/10/19 06:00 [pubmed] PHST- 2017/05/10 06:00 [medline] PHST- 2016/08/04 06:00 [entrez] AID - 000447558 [pii] AID - 10.1159/000447558 [doi] PST - ppublish SO - J Vasc Res. 2016;53(1-2):39-48. doi: 10.1159/000447558. Epub 2016 Aug 4.